title: Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data.
abstract: BACKGROUND
  Human papillomavirus (HPV) vaccination targeting females 12-13 years commenced in Australia in 2007, with catch-up of females 13-26 years until the end of 2009. No analyses of HPV vaccination program impact by either socioeconomic or geographic factors have been reported for Australia.
  
  
  METHODS
  Hospital admissions between July 2004-June 2011 involving a diagnosis of genital warts were obtained from a comprehensive national database. We compared sex- and age-specific admission rates in July 2006-June 2007 (pre-vaccination period) and July 2010-June 2011 (post-vaccination period) according to Index of Relative Socio-economic Disadvantage, nationally and stratified by remoteness area relating to the individual's area of residence, using Poisson/ negative binomial models.
  
  
  RESULTS
  Admission rates per 100,000 population in females aged 10-19 years (predominantly vaccinated at school), reduced from 42.2 to 6.0 (rate reduction 86.7 %; 95 % CI:82.2-90.0 %) in more disadvantaged areas and from 26.8 to 4.0 (85.0 %; 95 % CI:79.7-88.9 %) in less disadvantaged areas. In females aged 20-29 years (predominantly vaccinated in the community), the decreases were from 73.9 to 26.4 (66.0 %; 95 % CI:57.7-72.6 %) and from 61.9 to 23.8 (61.6 %; 95 % CI:52.9-68.7 %) in more and less disadvantaged areas, respectively. The reductions were similar in more vs less disadvantaged areas both inside major cities (88.6 %; 95 % CI: 82.2-92.7 % vs 87.9 %; 95 % CI:82.6-91.6 % in females aged 10-19 years; 64.0 %; 95 % CI:57.0-69.9 % vs 63.8 %; 95 % CI:52.9-72.1 % for females aged 20-29 years) and outside major cities (88.8 %; 95 % CI: 83.7-92.3 % vs 85.8 %; 95 % CI:73.5-92.4 % in females aged 10-19 years; 71.1 %; 95 % CI:58.8-79.7 % vs 67.6 %; 95 % CI:48.2-79.8 % for females aged 20-29 years). Admission rates in males aged 20-29 years also reduced, by 23.0 % (95 % CI:4.8-37.8 %) and 39.4 % (95 % CI:28.9-48.3 %) in more versus less disadvantaged areas respectively.
  
  
  CONCLUSIONS
  The relative reduction in genital warts appears similar in young females across different levels of disadvantage, including within and outside major cities, both for females predominantly vaccinated at school and in the community.
authors.affiliation: School of Public Health, University of Sydney, Sydney, NSW, 2006, Australia. megan.smith@nswcc.org.au.|Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia. megan.smith@nswcc.org.au.|Present address: Cancer Research Division, Cancer Council NSW, Kings Cross NSW 1340, PO Box 572, Sydney, NSW, 2011, Australia. megan.smith@nswcc.org.au.
authors.forename: Megan A
authors.initials: MA
authors.lastname: Smith
authors.affiliation: School of Public Health and Community Medicine, UNSW Australia, Sydney, NSW, 2052, Australia. bette.liu@unsw.edu.au.|The Sax Institute, Sydney, PO Box K617, Haymarket, NSW, 1240, Australia. bette.liu@unsw.edu.au.
authors.forename: Bette
authors.initials: B
authors.lastname: Liu
authors.affiliation: National Centre for Immunisation Research and Surveillance Children's Hospital, Westmead, Locked Mail Bag 4001, Sydney, 2145, NSW, Australia. peter.mcintyre@health.nsw.gov.au.
authors.forename: Peter
authors.initials: P
authors.lastname: McIntyre
authors.affiliation: National Centre for Immunisation Research and Surveillance Children's Hospital, Westmead, Locked Mail Bag 4001, Sydney, 2145, NSW, Australia. r.menzies@unsw.edu.au.|Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. r.menzies@unsw.edu.au.|Present address: School of Public Health and Community Medicine, UNSW Australia, Sydney, NSW, 2052, Australia. r.menzies@unsw.edu.au.
authors.forename: Robert
authors.initials: R
authors.lastname: Menzies
authors.affiliation: National Centre for Immunisation Research and Surveillance Children's Hospital, Westmead, Locked Mail Bag 4001, Sydney, 2145, NSW, Australia. aditi.dey@health.nsw.gov.au.
authors.forename: Aditi
authors.initials: A
authors.lastname: Dey
authors.affiliation: School of Public Health, University of Sydney, Sydney, NSW, 2006, Australia. karen.canfell@nswcc.org.au.|Prince of Wales Clinical School, UNSW Australia, Sydney, NSW, 2052, Australia. karen.canfell@nswcc.org.au.|Present address: Cancer Research Division, Cancer Council NSW, Kings Cross NSW 1340, PO Box 572, Sydney, NSW, 2011, Australia. karen.canfell@nswcc.org.au.
authors.forename: Karen
authors.initials: K
authors.lastname: Canfell
mesh_terms: D000293:Adolescent; D000328:Adult; D001315:Australia / Q000453:epidemiology; D002648:Child; D003218:Condylomata Acuminata / Q000453:epidemiology* / Q000517:prevention & control; D005260:Female; D006761:Hospitals; D006801:Humans; D008297:Male; D027383:Papillomaviridae / Q000276:immunology*; D012923:Social Class; D014611:Vaccination; D055815:Young Adult
references.citation: Vaccine. 2014 Jan 23;32(5):592-7
references.pmid: 24316239
references.citation: Vaccine. 2015 May 11;33(20):2387-94
references.pmid: 25843203
references.citation: J Public Health (Oxf). 2014 Mar;36(1):36-45
references.pmid: 23620542
references.citation: Lancet Infect Dis. 2014 Oct;14(10):958-66
references.pmid: 25107680
references.citation: Aust N Z J Public Health. 2014 Oct;38(5):419-23
references.pmid: 24962721
references.citation: Sex Health. 2014 Nov;11(5):481-94
references.pmid: 25377001
references.citation: J Infect Dis. 2015 Jan 1;211(1):91-9
references.pmid: 25117753
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1446-50
references.pmid: 23704476
references.citation: J Infect Dis. 2011 Dec 1;204(11):1711-22
references.pmid: 21964400
references.citation: BMC Public Health. 2011;11:172
references.pmid: 21426539
references.citation: J Adolesc Health. 2010 Apr;46(4 Suppl):S12-9
references.pmid: 20307839
references.citation: J Infect Dis. 2009 Mar 15;199(6):805-14
references.pmid: 19199546
references.citation: Vaccine. 2008 Jan 10;26(2):250-6
references.pmid: 18068276
references.citation: Med J Aust. 2004 Jun 21;180(12):618-22
references.pmid: 15200358
references.citation: Med J Aust. 2012 Apr 16;196(7):445
references.pmid: 22509873
references.citation: BMC Public Health. 2013;13:640
references.pmid: 23837819
references.citation: Euro Surveill. 2014;19(2). pii: 20677
references.pmid: 24457007